Assembly Biosciences, Inc.
ASMBNASDAQHealthcare● Active
$22.56
$-0.35(-1.51%)
Market Cap$358464382
P/E Ratio—
52W High$39.71
52W Low$15.54
Assembly Biosciences, Inc. (ASMB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ASMB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $72.30M | $28.52M | $7.16M | $0.00M | $6.25M |
| Cost of Revenue | $0.13M | $0.00M | $48.90M | $69.08M | $0.00M |
| Gross Profit | $72.17M | $28.52M | ($41.74M) | ($69.08M) | $6.25M |
| Gross Margin %(computed) | 99.82% | 100.00% | -582.67% | — | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $64.81M | $55.93M | $48.90M | $69.98M | $68.52M |
| G&A Expenses | $19.61M | $18.01M | $22.91M | $23.93M | $28.78M |
| Total Operating Expenses | $84.42M | $73.94M | $22.91M | $25.03M | $138.94M |
| Operating Income | ($12.12M) | ($45.42M) | ($64.65M) | ($94.11M) | ($132.69M) |
| Operating Margin %(computed) | -16.76% | -159.26% | -902.50% | — | — |
| Interest Income | $6.00M | $5.57M | $3.45M | $1.02M | $0.30M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($6.12M) | ($39.85M) | ($61.20M) | ($93.09M) | ($132.39M) |
| Income Tax Expense | $0.00M | $0.33M | $0.03M | $0.00M | ($2.53M) |
| Net Income | ($6.12M) | ($40.18M) | ($61.23M) | ($93.09M) | ($129.85M) |
| Net Margin %(computed) | -8.47% | -140.87% | -854.78% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.55 | $-6.69 | $-13.38 | $-22.82 | $-36.00 |
| Wtd Avg Shares | 11.21M | 6.00M | 4.58M | 4.03M | 3.61M |
| EBITDA | ($11.99M) | ($45.29M) | ($64.20M) | ($92.52M) | ($90.58M) |
| EBITDA Margin %(computed) | -16.58% | -158.80% | -896.22% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Assembly Biosciences, Inc. data
About Assembly Biosciences, Inc. (ASMB) Income Statement
Assembly Biosciences, Inc. (ASMB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ASMB reported revenue of $0.07B, gross profit of $0.07B (gross margin 99.82%), and net income of ($0.01B) — a net profit margin of -8.47%.
Frequently asked questions
ASMB · 4 questionsAssembly Biosciences, Inc. (ASMB) reported revenue of $0.07B for 2025, up 153.5% year-over-year.
ASMB revenueASMB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08